Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3921-3930 Newer>

The Motley Fool July 27, 2007 Rich Smith	Foolish Forecast: Double LCA-Vision? LASIK specialist LCA-Vision foresees a very bright future, with more market share, more economies of scale, more pricing power and more profits.
The Motley Fool July 27, 2007 Brian Orelli	Stability From a Likely Source Becton Dickinson's earnings are solid. The medical device and lab supply company has reported growth in earnings and increases in margins.
The Motley Fool July 27, 2007	Shire's Got Focus: Fool by Numbers Revenue and guidance are up at Shire, led by improved sales of their ADHD drugs.
The Motley Fool July 27, 2007 Rich Duprey	Sniffing Out Bentley's New Patent To succeed in insulin therapy, the generic drugmaker must overcome patent expiration. Investors, take note.
Managed Care July 2007 Tom Reinke	Better Ways to Pay Providers Paying for coordinating care and for packages of services -- bundling and episodes of care -- may be the best bet for a modification of the unfettered fee-for-service system.
Managed Care July 2007 Martin Sipkoff	Hospitals Asked To Account For Errors on Their Watch Centers for Medicare & Medicaid Services and states may stop paying for specific hospital-acquired conditions. Will health plans follow suit?
Managed Care July 2007 Alan Adler	Why Blogs? Don't dismiss this development in Web communication. Blogs -- the best of them -- conduct serious and extensive discussions of health care policy and provide important new information.
Managed Care July 2007 Smith et al.	Determining the Cost-Effectiveness of a Computer-Based Smoking Cessation Intervention in Primary Care From a physician's practice perspective, the stage-based computer tailored intervention was cost-effective relative to standard care. Incorporation of partial behavior change into the model further enhanced the cost-effectiveness ratio.
The Motley Fool July 26, 2007 Brian Orelli	Affymetrix Advances New products and services should help Affymetrix regain market share. Yesterday, the company even announced a small second-quarter profit.
The Motley Fool July 26, 2007 Brian Lawler	Lilly Doesn't Wilt The second quarter was another good one for Eli Lilly. Top-line and bottom-line both grew.
<Older 3921-3930 Newer> Return to current articles.